top of page
< Back

Cellicure, Inc

Founded Year:



Life Science/Biotech


Pre-A to Series A



Cellicure provides innovative cell-based immunotherapy technologies, customized treatment regimens and real-world solutions for the current unmet therapeutic needs created by cancer, infectious diseases, and chronic inflammatory diseases. The company has a rich pipeline of products and has established cutting-edge R&D centers, along with GMP manufacturing facilities.

What Founders say:

Frank Q.Li, MD, Ph.D.
Frank Q.Li, MD, Ph.D.
Co-founder & CEO

"The H7 Accelerator program aligns perfectly with early-stage biotech like Cellicure. We're excited to connect with industry leaders for invaluable guidance. The program's mentorship sessions, workshops, seminars, and networking events offer valuable resources for our growth and success."

bottom of page